For women in menopause, GLP-1s can offer more than just scale-wins
This includes assessment of thyroid function, kidney and liver biomarkers, and gastrointestinal history
Concurrent Medications: Patients taking other medications alongside semaglutide might experience an increased risk of itching due to drug interactions
A Virta Health paper, yet to be released, shows a safe off-ramp may be possible, as hemoglobin A1c and body weight measured 12 months after de-prescription did not significantly differ between patients that continued GLP-1 usage and those that did not
However, this scenario applies to a minority of patients
FDA does not treat cosmetics the same way it treats prescription drugs, and FDA has specifically flagged compounded injectable GHK-Cu as a safety concern [8], [11]